Biotec Pharmacon

Biotec Pharmacon ASA is a publicly listed company at the stock exchange (Oslo Børs). The company is a principle contributor in the field of developing immunomodulatory products and cold adapted marine enzymes. The company operates through its subsidiaries Biotec BetaGlucans (100% owned) and ArcticZymes (96%).

Biotec Pharmacon is partner in Centre for Marine Bioactives and Drug Discovery, MabCent-SFI.

 

 

Contact

Biotec Pharmacon
Sykehusveien 23

PO Box 6463
NO-9294 Tromsø
Norway

Phone: +47 77 64 89 00
Fax: +47 77 64 89 01

Website

www.biotec.no